[1]Sheely AM, Gaddis NC, Choi JD, et al.Isolation of a human genethat inhibits HIV-1 infection and is suppresed by the viral Vif pro-tein[J].Nature, 2002, 418 (6898) ∶646-50.
|
[2]Tureilli P, Mangeat B, Jost S, et al.Inhibition of hepatitis B virusreplication by APOBEC3G[J].Science, 2004, 303 (5665) ∶1829.
|
[3]中华医学会.慢性乙型肝炎防治指南[J].中华肝脏病杂志, 2005 (12) ∶15-25.
|
[4]Livak KJ, Schmittgen TD.Analysis of relative gene expressiion datausing real-time quantitative PCR and the 2 (-Delta Delta C (T) ) Method[J].Methods, 2001, 25 (4) ∶402-8.
|
[5]Mangeat B, Turelli P, Caron G, et al.Broad antiretroviral defenceby human APOBEC3G through lethal editing of nascent reverse tran-scripts[J].Nature, 2003, 424 (6944) ∶99-103.
|
[6]Jarmuz A, Chester A, Bayliss J, et al.An anthropoid-specific lo-cus of orphan C to U RNA-editing enzymes on chromosome22[J].Genomics, 2002, 79 (3) ∶285-96.
|
[7]Harris RS, Bishop KN, Sheehy AM, et al.DNA deamination medi-ates innate immunity to retroviral infection[J].Cell, 2003, 113 (6) ∶803-9.
|
[8]Lie-Injo LE, Balasegaram M, Lopez CG, et al.Hepatitis B virusDNA in liver and white blood cells of patients with hepatoma[J].DNA, 1983, 2 (4) ∶301-8.
|
[9]Rosenberg W.Mechanisms of immune escape in viral hepatitis[J].Gut, 1999, 44 (5) ∶759-64.
|
[10]Tanaka Y, Marusawa H, Seno H, et al.Anti-viral protein APO-BEC3G is induced by interferon-alpha stimulation in human hepa-tocytes[J].Biochem Biophys Res Commun, 2006, 341 (2) ∶314-9.
|
[11]Peng G, Lei KJ, Jin W, et al.Induction of APOBEC3 family pro-teins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity[J].J Exp Med, 2006, 203 (1) ∶41-6.
|
[12]Komohara Y, Yano H, Shichi jo S, et al.High expression of APO-BEC3G in patients infected with hepatitis C virus[J].J Mol Histol, 2006, 37 (8-9) ∶327-32.
|
[13]Chiu YL, Witkowska HE, Hall SC, et al.High-molecular-massAPOBEC3G complexes restrict Alu retrotransposition[J].ProcNat1 Acad Sci US A, 2006, 103 (42) ∶15588-93.
|
[14]Chen K, Huang J, Zhang C, et al.Alpha interferon potently en-hances the anti-human immunodeficiency virus type 1 activity ofAPOBEC3G in resting primary CD4 T cells[J].J Virol, 2006, 80 (15) ∶7645-57.
|
[15]Stopak KS, Chiu YL, Kropp J, et al.Distinct Patterns of CytokineRegulation of APOBEC3G Expression and Activity in Primary Lym-phocytes, Macrophages, and Dendritic Cell[J].J Biol Chem, 2007, 282 (6) ∶3539-46.
|
[1] | Chen Hao, Hao JianHeng, Li ZhenCheng, Xu HuiChao, Gao Yan, Miao YuChuan, Hao HuiQin, Liu Yang. Screening for differentially expressed genes in mice with autoimmune hepatitis and effect of saikosaponin-d on the expression of several differentially expressed genes[J]. Journal of Clinical Hepatology, 2020, 36(4): 840-846. doi: 10.3969/j.issn.1001-5256.2020.04.026 |
[2] | Shi HaiYan, Li LiYa, He HaoLan, Liu HuiYuan, Chen ZhiMin, Chen WeiLie, Liao BaoLin. Association of HBV precore/core promoter variants with the degree of liver fibrosis in patients with HBeAg-positive chronic hepatitis B[J]. Journal of Clinical Hepatology, 2018, 34(5): 1020-1024. doi: 10.3969/j.issn.1001-5256.2018.05.019 |
[3] | Zhou LianLian, Shen Mo, Zhou Ping, Zhou Wu, Lin XiangYang. HBV genotype distribution and its relationship with serum HBV DNA level and HBeAg expression among patients with chronic hepatitis B in southern Zhejiang Province, China[J]. Journal of Clinical Hepatology, 2014, 30(10): 1039-1041. doi: 10.3969/j.issn.1001-5256.2014.10.016 |
[4] | Deng Le, Wen ZhiLi. Review of recent research progress in correlating HBV genotypes with efficacy of antiviral treatments[J]. Journal of Clinical Hepatology, 2012, 28(6): 469-473. |
[5] | Yang YanLin, Xiao Ping, Gao Peng, Wang LiMing, Wei XiSheng, He Qiang, Zhou Ping. Distribution of HBV genotypes and YMDD mutations in E antigen-positive patients[J]. Journal of Clinical Hepatology, 2012, 28(6): 428-430. |
[6] | Guo XinHui, Yan Yan, Li Zhuo, Yin JiMing. Fluorescent reverse transcription-PCR assay for determination of hepatitis C virus genotypes[J]. Journal of Clinical Hepatology, 2011, 27(1): 65-67. |
[7] | Cheng Ling, Hong GuoHu, Guo Yan, Mao Qing. Prediction of HLA-DRB1*0311/0401 in recognizing epitopes of HCV Core protein of different genotypes[J]. Journal of Clinical Hepatology, 2011, 27(1): 61-64. |
[8] | Liu JinPing, Liu YouDe, Guo YanMei, Yang ShaoPing, Lin Qing, Lin Ling. Clinical characteristics and distribution of hepatitis B virus genotypes in CHB patients in Yantai area[J]. Journal of Clinical Hepatology, 2011, 27(12): 1288-1290. |
[9] | Zhang WenJie, Liu LiJun, Du ShaoCai, Li ChaoXia, Lu QingYun, Yang ShaoHua. The prevalence of hepatitis C virus genotype in Lanzhou area[J]. Journal of Clinical Hepatology, 2010, 26(3): 290-291+294. |
[10] | Wang GuoQiang, Niu JuXia. The HBx protein mutation among different HBV genotypes[J]. Journal of Clinical Hepatology, 2010, 26(4): 392-394. |
[12] | Li Jun, Chen XinYue, Zhao Hong, Yu YanYan, Si ChongWen, Han ZhongHou, Zhang WenJin, Chen YuPing, Chen Yong, Wang GuiQiang, Yu Min, Gong WeiBo, Xu JingHang, Wang Jun, Lin XiaoHong, Li XueYing. The relationship of hepatitis B virus genotypes and efficacy of lamivudine and interferon alpha 2b in the treatment of HBeAg-positive chronic hepatitis B[J]. Journal of Clinical Hepatology, 2008, 24(3): 169-171. |
[13] | Xiao Yang, Hu CaoHan, Zhou YueJin, Xie QingRong, Zhu BingXing, Hu Xia, Wang KaiJian, Zhang WenJing. Effect of hepatitis B virus genotypes on response to interferon α2b in the treatment of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2006, 22(2): 105-106. |
[15] | Liu ChengYong, Hou YuanPei, Qian XiuMei, Sun Qing, Song Li. Distribution of hepatitis B virus genotype in Xuzhou and its clinical significance[J]. Journal of Clinical Hepatology, 2005, 21(3): 151-152. |
[16] | Li TingMing, Zhu YouFu, He HaiTang, Mao QianGuo, Wu AiHua, Liang YuFang, Luo KangXian. The relation between chinese hepatitis B virus genotype B C and efficacy of interferon-α.[J]. Journal of Clinical Hepatology, 2005, 21(1): 16-18. |
[17] | Xu ZhengJu, Yang Hong, Zhang QiHua, Chen XianLi, Li ShuQing, Wang ChongGuo. Study on the relationship between hepatitis B virus genotypes and effect of lamivudine therapy.[J]. Journal of Clinical Hepatology, 2005, 21(3): 157-159. |
[18] | Jiao Jian, Wang JiangBin. Distribution of HCV genotypes and its clinical features in patients coinfected with HCV and HBV[J]. Journal of Clinical Hepatology, 2004, 20(2): 75-76. |
[19] | Lu YinYing, Wang Lin, Liu Yan, Li Ke, Cheng Jun, Zhang LingXia, Li Li. Cloning and expression of gene of hepatitis B virus e antigen in yeast[J]. Journal of Clinical Hepatology, 2003, 19(3): 166-168. |
[20] | Yao Gang, Zhang Lian, Bao LiHua. HBV genotypes and efficacy of interferon-α on patients with chronic hepatitis B.[J]. Journal of Clinical Hepatology, 2002, 18(5): 273-274. |